Fairness to Kids with Cancer Act of 2025

Bill Number

H.R. 6054

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-11-17: Referred to the House Committee on Energy and Commerce.

Last Updated

2025-12-19T09:07:57Z

AI-Generated Summary

Purpose

The Fairness to Kids with Cancer Act of 2025 aims to guarantee that a proportionate share of federal funding for cancer research is allocated specifically to pediatric (childhood) cancer research. This ensures that research efforts reflect the proportion of the U.S. population under age 18, addressing potential underfunding of pediatric cancers relative to adult cancers.

Key Provisions

• Funding Allocation Requirement: Starting in fiscal year 2026 and for all subsequent years, the President must ensure that the percentage of total federal cancer research funds dedicated to pediatric cancer matches the percentage of the U.S. population under 18 years old.
• Calculation Method: The required percentage is based on U.S. Census Bureau data from the end of the prior fiscal year, using the ratio of individuals under 18 to the total U.S. population (e.g., if children under 18 make up about 22% of the population, at least 22% of cancer research funds must go to pediatric research).
• Scope: Applies to all federal funds "obligated" (committed or allocated) for cancer research across government agencies.

Significant Changes to Existing Law

• This bill introduces a new mandatory benchmark for federal cancer research funding, which was not previously required by law. Prior to this, pediatric cancer research funding was determined through annual appropriations and agency priorities without a fixed proportional tie to population demographics.
• It shifts discretion from agencies (like the National Institutes of Health) to a population-based formula, potentially overriding informal or historical allocation practices that favored adult cancers.

Potential Impacts

• On Government Agencies: Agencies such as the National Institutes of Health (NIH) or the National Cancer Institute (NCI) may need to reallocate budgets, adjust grant processes, or seek additional funding to meet the percentage requirement, which could strain resources if total cancer research funding does not increase.
• On Citizens: Families of children with cancer could benefit from more targeted research, potentially leading to improved treatments, earlier detections, and better survival rates for pediatric cancers. It promotes equity by ensuring youth-specific needs are not overlooked in broader cancer efforts.
• On International Relations: Minimal direct impact, though increased U.S. pediatric cancer research could enhance global collaborations or position the U.S. as a leader in childhood oncology, indirectly benefiting international health initiatives.

Main Stakeholders Affected

• Children Under 18 and Their Families: Primary beneficiaries, as they gain from expanded research into pediatric cancers, which affect about 15,000 U.S. children annually and often differ from adult cancers in biology and treatment.
• Cancer Researchers and Medical Community: Pediatric oncologists, scientists, and institutions focused on childhood cancer will see more funding opportunities, while adult cancer researchers might face competition for resources.
• Federal Government and Taxpayers: The President, Congress, and agencies like the NIH must implement and monitor compliance, with taxpayers funding the overall cancer research pool (which exceeds $6 billion annually).
• Advocacy Groups: Organizations representing pediatric cancer patients, such as the Children's Oncology Group, stand to gain influence in shaping research priorities.

Notable Legal, Constitutional, or Political Implications

• Legal: The bill imposes a clear, enforceable duty on the President, which could lead to judicial review if allocations fall short (e.g., via lawsuits from advocacy groups). It relies on Census data for objectivity but does not specify penalties for non-compliance, leaving enforcement to congressional oversight.
• Constitutional: Aligns with Congress's power to appropriate funds (Article I, Section 9) and direct executive action, without raising separation-of-powers concerns, as it guides rather than micromanages agency spending.
• Political: Highlights bipartisan support (introduced by representatives from both parties) for pediatric health equity, potentially pressuring future budgets to increase total cancer funding to avoid cuts elsewhere. It may spark debates on resource allocation in healthcare, emphasizing fairness for vulnerable populations like children.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Fitzpatrick, Brian K. [R-PA-1]

Cosponsors (6)

Rep. Evans, Dwight [D-PA-3], Rep. Kelly, Mike [R-PA-16], Rep. Lee, Susie [D-NV-3], Rep. Stefanik, Elise M. [R-NY-21], Rep. Gottheimer, Josh [D-NJ-5], Rep. Neguse, Joe [D-CO-2]

Recent Actions

• 2025-11-17: Referred to the House Committee on Energy and Commerce.
• 2025-11-17: Introduced in House
• 2025-11-17: Introduced in House

Bill Versions

• Fairness to Kids with Cancer Act of 2025 — issued 2025-11-17 — PDF (2 pages)